Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 52.20

-5.5%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (8871)	7/28/2003 6:14:31 PM
From: Biomaven	Read Replies (1) of 52153

>>lower cost of goods>> Why, how? Straightforward - increased potency means smaller doses. Not that relevant for a small molecule, but quite relevant for a biological. I'm assuming they don't lose anything in production efficiency, which may not be true in the short run but presumably would be true after a year or two of production. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next